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Human T-lymphotropic virus type 1 (HTLV-1) is
associated with adult T-cell leukemia (ATL) and
HTLV-1 associated myelopathy/tropical spastic
paraparesis (HAM/TSP) and has also been
implicated in several disorders, including
periodontal disease. The proviral load is an
important biological marker for understanding
HTLV-1 pathogenesis and elucidating whether
or not the virus is related to the clinical mani-
festation of the disease. This study describes
the oral health proﬁle of HTLV-1 carriers and
HAM/TSP patients in order to investigate the
association between the proviral load in saliva
and the severity of the periodontal disease and
to examine virus intra-host variations from pe-
ripheral blood mononuclear cells and saliva
cells. It is a cross-sectional analytical study of
90 individuals carried out from November 2006
to May 2008. Of the patients, 60 were HTLV-1
positive and 30 were negative. Individuals from
the HTLV-1 positive and negative groups had
similar mean age and social-economic status.
Data were analyzed using two available statisti-
cal software packages, STATA 8.0 and SPSS
11.0 to conduct frequency analysis. Differences
of P < 0.05 were considered statistically signiﬁ-
cant. HTLV-1 patients had poorer oral health
status when compared to seronegative individ-
uals. A weak positive correlation between
blood and saliva proviral loads was observed.
The mean values of proviral load in blood and
saliva in patients with HAM/TSP was greater
than those in HTLV-1 carriers. The HTLV-1
molecular analysis from PBMC and saliva
specimens suggests that HTLV-1 in saliva is
due to lymphocyte inﬁltration from peripheral
blood. A direct relationship between the
proviral load in saliva and oral manifesta-
tions was observed. J. Med. Virol. 84:1428–
1436, 2012.  2012 Wiley Periodicals, Inc.
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INTRODUCTION
Human T-lymphotropic virus type 1 (HTLV-1) was
the ﬁrst human retrovirus described [Poiez et al.,
1980]. HTLV-1 is endemic in Southwestern Japan,
Melanesia, Caribbean Islands, Central and South
America, as well as in parts of Africa. It has been esti-
mated that 20 million people are infected worldwide
[Catalan-Soares et al., 2001; Proietti et al., 2005].
Salvador, the capital city of the State of Bahia located
in Northeastern Brazil, has the highest described
prevalence of HTLV-1 in Brazil. A cross-sectional
population-based study carried out in Salvador found
a prevalence of HTLV-1 infection of 1.7%, estimating
that approximately 50,000 individuals were infected
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by this retrovirus [Dourado et al., 2003]. Another
survey carried out in the city reported that 0.45%
of blood donors had HTLV-1 infection [Mota et al.,
2006]. In an earlier study, a prevalence of 1.35% had
been found in the same group, suggesting an apparent
decrease in the infection in blood donors over the
last decade in Salvador [Galva˜o-Castro et al., 1997].
HTLV-1 is associated with adult T-cell leukemia
(ATL) [Poiez et al., 1980] and HTLV-1 associated
myelopathy/tropical spastic paraparesis (HAM/TSP)
[Gessain et al., 1985; Osame et al., 1985] and has
also been implicated in several disorders, such as
uveitis [Mochizuki et al., 1996], Sjo¨gren’s syndrome
[Nakamura et al., 2000], polymyositis [Cruz et al.,
2005], and infective dermatitis [La Grenade et al.,
1998].
Although the scientiﬁc literature correlates Sjo¨gren
syndrome with HTLV-1, this association is unclear.
Some authors suggest that the association of IgA
anti-HTLV-1 in saliva of patients with Sjogren’s syn-
drome is more common than in saliva of patients with
HAM/TSP or HTLV-1 carriers [Terada et al., 1994].
Although the virus has been isolated from lympho-
cytes present in saliva of infected patients, HTLV-1
transmission is not feasible in this way due to the low
concentration of the virus in saliva, as well as the
presence of neutralizing antibodies as salivary IgG
[Yamamoto et al., 1995]. It is noteworthy that leuko-
cytes found in whole saliva, including lymphocytes,
represent only a very tiny proportion of those found in
blood [Jorge, 1998].
HTLV-1 sequences were detected in salivary gland
tissue from patients with HAM/TSP as well in sero-
positive patients without neurological disease. In this
report, HTLV-1 proviral DNA was detected by the po-
lymerase chain reaction (PCR) ampliﬁcation in DNA
extracted from lip biopsies of every patients. Virus
RNA was detected by in situ hybridization in acini
epithelium, as well as in lymphocytic inﬁltrates. The
authors suggest that the presence of HTLV-1 tax
sequence expression in salivary glands could partici-
pate in the inﬂammatory lesions observed in infected
patients [Tangy et al., 1999]. European investigators
have also detected the HTLV-1 tax gene in biopsy
specimens of salivary glands from patients with Sjo¨g-
ren’s syndrome and other inﬂammatory processes.
The gene was detected in biopsy specimens of salivary
glands in 15 out of the 50 patients with Sjo¨gren’s
syndrome. The study also showed the presence of this
gene in 9 out of 32 patients with other inﬂammatory
diseases involving salivary glands, such as graft-
versus-host disease, sarcoidosis, and extravasated
cysts, and from only 1 out of 26 patients with normal
salivary glands [Mariette et al., 2000].
A Brazilian survey of patients infected with HTLV-
1 was conducted in Salvador, Bahia, associating peri-
odontal diseases, stomatitis, and dry mouth with the
virus infection [Giozza, 2006]. It has been suggested
that the HTLV-1 infection may be implicated in peri-
odontal disease due to the altered levels of cytokines
[Garlet et al., 2010]. Iinfection with HTLV-1 promotes
an exacerbated inﬂammatory immune response, pos-
sibly associated with an impaired Treg activity in
response to a usual pattern of periodontal infection.
Proviral load is an important biological marker to
understand HTLV-1 pathogenesis and to elucidate
whether or not the virus is related to the clinical
manifestation of the disease. HAM/TSP individuals
usually have a higher proviral load when compared
to asymptomatic ones [Haddad, 2004; Yakova et al.,
2005]. The association between rheumatoid arthritis,
as well as Sjo¨gren’s syndrome, with HAM/TSP has
been described [Ferraz-Chaoui et al., 2010]. There
are few studies evaluating oral disease in HTLV-1-
infected patients.
This study aimed to describe the oral heath proﬁle
of HTLV-1 carriers (no-HAM/TSP) and HAM/TSP
patients, to investigate the association between the
proviral load in saliva and the severity of periodontal
disease and to analyze virus intra-host variations
from peripheral blood mononuclear cells (PBMC) and
saliva cells from persons infected with HTLV-1.
MATERIALS AND METHODS
Study design and population
This cross-sectional analytical study was conducted
at the Integrative and Multidisciplinary Center for
HTLV at the Bahiana School of Medicine and Public
Health (EBMSP), Salvador, Bahia, Brazil. Ninety
individuals, 65 females (72%), participated in this
survey from November 2006 to May 2008. Of the
patients, 60 were HTLV-1 positive and 30 were nega-
tive. Individuals from the HTLV-1 positive and nega-
tive groups had similar mean age and social-economic
status. The diagnosis of HAM/TSP was determined
according to WHO guidelines [Osame, 1990]. The
study protocols were approved by the Ethical Review
Board from EBMSP, under protocol number 28/2006,
respecting the Brazilian Health National Council
Resolution 196/96, as well as the Helsinki Declara-
tion, 2008. All the volunteers provided written
informed consent before sharing the research
protocol.
Laboratory, Clinical, and
Stomatological Diagnosis
Before clinical examination, 3 ml of saliva were col-
lected from the HTLV positive patients in a sterile
plastic centrifuge tube of 50 ml and frozen (708C) for
subsequent detection of proviral load in saliva. In
order to quantify the proviral load in peripheral blood,
10 ml of peripheral blood was collected in tubes con-
taining EDTA for PBMC isolation by density gradient
using the Ficoll–Hypaque technique.
All patients were examined for their oral health in
accordance with standards established by the World
Health Organization for periodontal disease [WHO,
1999]. The following parameters were evaluated:
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clinical attachment loss (CAL), probing pocket depth
(PPD), tooth mobility, and DMFT index represented
as the number of decayed/missing/ﬁlled teeth. A sali-
vary ﬂow test was conducted [Krasse, 1998; Thylstrup
and Fejerskov, 2001] and a ﬂow of saliva between
1 and 3 ml/min was classiﬁed as normal while less
than 1 ml/min was considered to be reduced.
Genomic DNA from PBMCswas extracted using
a commercially available kit, QIAamp DNA Blood Kit
(Qiagen, Valencia, CA), and measured by spectropho-
tometry. DNA extraction in saliva followed a similar
technique used for PBMCs, except that each milliliter
of saliva was mixed with 4 ml of PBS (pH 7.1) and
centrifuged at room temperature for 5 min at 1,700g.
The precipitate was resuspended in 180 ml of PBS af-
ter the supernatant had been discarded. The proviral
load of HTLV-1 in PBMC was determined by quanti-
tative real-time PCR, using 106 PBMC and the albu-
min gene as an endogenous human genomic control.
The quantitation of proviral DNA was calculated by
the number of copies of the HTLV-1 per 106 cells as
previously described [Dehee et al., 2002]. The HTLV-1
proviral load in the saliva was quantiﬁed using the
DNA from saliva and the result was given as the
number of copies of HTLV in 3 ml of saliva. The mo-
lecular biology studies were performed at the Gonc¸alo
Muniz Research Center (CPqGM)/Oswaldo Cruz
Foundation, Bahia (FIOCRUZ/BA).
DNA from PBMCs was submitted to a nested-PCR
with speciﬁc primers for the long-terminal repeat
(LTR) genomic region of HTLV. The tax-LTR segment
of 479 bp was ampliﬁed to HTLV-1 as previously de-
scribed [Alcantara et al., 2006], and all PCR products
were puriﬁed using the QIAGEN PCR puriﬁcation
Kit.
Molecular cloning. From the PCR positive sam-
ples, molecular cloning was performed using TOPO
TA Cloning1 Kit following the manufacturer’s ins-
tructions, and at least 10 colonies of each sample were
selected for DNA isolation from plasmids by Wizard1
Plus SV Minipreps DNA Puriﬁcation System (Promega,
Madison, WI). From isolated DNA, an enzymatic reac-
tion with the EcoRI enzyme was performed to verify
the insert presence. DNA was sequenced from plas-
mids using the Taq FS Dye terminator cycle sequenc-
ing kit (Applied Biosystems, Foster City, CA) using an
automated 3100 genetic analyzer (Applied Biosystems
Inc.), with the same inner primers.
Molecular analysis. The new LTR sequences
were aligned using the ClustalX software [Thompson
et al., 1997], and manually edited using the GeneDoc
[Nicholas et al., 1997] program. Phylogenetic analysis
was performed using the maximum-likelihood (ML)
and neighbor-joining (NJ) methods of PAUP, version
4.0b.10 [Swofford, 1998]. The Hasegawa–Kishino–
Yano (HKY) evolutionary model (which takes into
account variable base frequencies and variable transi-
tion and transversion frequencies) was selected by
Modeltest 3.7 software [Posada and Crandall, 1998].
The reliability of the NJ trees was assessed by
analyzing 1,000 bootstrap replicates. For ML trees,
a heuristic search was performed with a subtree–
pruning–regrafting branch swapping algorithm in-
cluding its optimized parameters. Trees were drawn
with FigTree version 1.3.1 (available at http://tree.
bio.ed.ac.uk/software).
To analyze the presence of one post-translational
modiﬁcation sites proﬁle at PBMC and mouthwash
cells, the tax fragment was translated by GeneDoc
software and the protein sequences were submitted
to the Prosite tool in the GeneDoc software. The non-
parametric test for panmixia, Hudson test, was per-
formed to analyze the mean pairwise difference (Ks)
and the mean pairwise log (Ks) within each sample
to verify the HTLV-1 clonal proﬁle between PBMC
and mouthwash cells. The results were signiﬁcant if
P < 0.005. Means of the genetic distances within
the HTLV-1 clones were measured using the Kimura
2-parameter substitution model, implemented in
Mega3 software [Kumar et al., 1994].
Statistical Analysis
Two available statistical software packages, STATA
8.0 and SPSS 11.0, were used to carry out frequency
analysis. The chi-squared test was used to verify
proportion and prevalence ratio differences, as well as
Fisher’s exact test (CI ¼ 95%). In order to compare
means of age and DMFT between the seropositive and
seronegative groups, the t-test was used and logistic
regression was performed to investigate the associa-
tion between proviral load in saliva and depression
or HAM/TSP, controlling for the relevant covariable.
Differences of P < 0.05 were considered statistically
signiﬁcant.
RESULTS
The socio-demographic proﬁle of both groups,
HTLV-1 positive and negative (Table I) showed a pre-
dominance of females (78.3% and 60%, respectively),
aged 31–50 years (60% and 46.7%), low income (48.3%
and 43.3%), and education (58.3% and 46.7%). Both
groups had a high prevalence of cariogenic food intake
(83.3% and 76.7%, respectively). All risk factors
for the acquisition of HTLV-1 such as the use
of injectable drugs, sexually transmitted diseases,
unprotected sex and multi-partner sex were similar
in both groups, except blood transfusion which was
more frequent in the seropositive group (25%) than in
negative one (6.6%).
Oral health evaluation
The main clinical complaints related to oral health
(sensation of dry mouth, dysphagia, and ocular dry-
ness) were more frequent among individuals from the
HTLV-1 positive group (Table II). The agreement
between the individual perception of dry mouth and
hyposalivation, as measured by the siaolometric test
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was 67.7% (kappa ¼ 0.326; P ¼ 0.002). The agree-
ment between complaints of dryness of the mucus
membrane and hyposalivation 56.6% (kappa ¼ 0.15,
P ¼ 0.828) and between xeroftalmy and hyposaliva-
tion 55.5% (kappa ¼ 0.001, P ¼ 0.995) was poor.
Oral health status, as measured by mean DMTF
was higher in the HTLV-1 positive group (21) than in
the negative group (16.4). On stratifying mean DMFT
by gender and HTLV-1 infection, it was observed that
mean DMFT was higher in the HTLV-1 positive
group, regardless of gender (mean values of 21 and
22, for positive females and males, respectively,
whereas the mean DMFT were 13 and 18 for females
and males in the negative group).
The relative proportions of complaints of dry mouth,
decreased salivary ﬂow, periodontal disease, and
gingival attachment loss were higher in the HTLV-1
positive group. Although tooth mobility was higher in
seropositive group, it was not statistically signiﬁcant
(Table III).
Pathological ﬁndings of oral lesions were more fre-
quent among individuals from the HTLV-1 positive
group. Stomatitis, abscess, and ﬁstula were positively
associated with HTLV-1 infection (PR ¼ 2.87, 95%
TABLE I. Socio-Demographic Characteristics and Cariogenic Diet of HTLV-1 Positive and Negative Groups
Variables
HTLV-1
Positive (n ¼ 60) Negative (n ¼ 30)
P-valueN % N %
Age mean (SD) in years 42.1 13.0 36.9 13.1 0.080
Sex 0.083
Female 47 78.3 18 60.0
Male 13 21.7 12 40.0
Age (years)
18–30 11 18.3 10 33.3 0.273
31–50 36 60.0 14 46.7
>50 13 21.7 6 20.0
Skin color (self-identified) 0.452
White 17 28.3 6 20.0
Not White 43 71.7 24 80.0
Education (years) 0.367
8 35 58.3 14 46.7
>8 25 41.7 16 53.3
Income 0.695
<1 MW 29 48.3 13 43.3
¼1 MW 22 36.7 9 30.0
2 MW 9 15.0 8 26.7
Cariogenic diet 1.000
Yes 50 83.3 23 76.7
No 10 16.7 7 23.3
SD, standard deviation; MW, minimum wage, approximately US$ 345.00.
TABLE II. Clinical Complaints From Individuals From HTLV-1 Positive and Negative Groups
Variables
HTLV-1 infection
Positive (n ¼ 60) Negative (n ¼ 30)
P-valueN % N %
Oral burning symptoms 0.463
Yes 6 10.0 2 6.7
No 54 90.0 28 93.3
Prosthesis retention difficulties 0.457
Yes 4 6.7 1 3.3
No 56 93.3 29 96.7
Dysphagia 0.027
Yes 9 15.0 0 0.0
No 51 85.0 30 100.0
Dry mouth 0.020
Yes 28 46.7 6 20.0
No 32 53.3 24 80.0
Dry eyes 0.046
Yes 15 25.0 2 6.7
No 45 75.0 28 93.3
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CI: 1.09–7.56). Reduced salivary ﬂow (PR ¼ 2.14, 95%
CI: 1.07–4.30) and periodontitis (PR ¼ 1.96, 95% CI:
1.11–3.49) were more prevalent among individuals
from the HTLV-1 positive group.
HTLV-1 Positive Group Analysis
The proviral load from the blood and saliva of the
individuals from the HTLV-1 positive group showed
a weak positive correlation between blood and saliva
proviral loads (R ¼ 0.28, P ¼ 0.04; Fig. 1). The
amount of the virus in saliva (0.02–6.00 copies of
HTLV pol gene/3 ml of saliva) was lower than the
quantity detected in the blood (633.0–583,765.0 copies
of HTLV pol gene/copies of albumin  2  106).
HAM/TSP patients had mean values of proviral
load in blood (118,839.9 vs. 65,280.2, P ¼ 0.106) and
in saliva (1.1 vs. 0.4, P ¼ 0.154) higher than that
found among the asymptomatic patients. After per-
forming the quantitation of proviral load in saliva of
56 patients (21 had HAM/TSP), the proviral DNA was
detected in 18 individuals, 9 with HAM/TSP, and 9
HTLV-1 carriers. However, the proviral load was not
associated to any neurological manifestation.
Oral and dental manifestations were more frequent
among HAM/TSP patients than among the HTLV-1
carriers, particularly concerning periodontal disease:
tooth mobility (36% and 28.6%), periodontitis (64%
and 57.1%), and loss of gingival attachment (64% and
45.7%; Table IV). However, periodontal disease was
not more frequent among those who had a detectable
proviral load in their saliva.
Salivary flow evaluation
Salivary ﬂow did not show relevant differences
according to the use of medication, age, diabetes mel-
litus, or hypertension in both positive and negative
groups. In HTLV-1 negative patients, 4 of the 6
(66.7%) patients with PD and hyposalivation were
at an advanced stage, whereas 22.7% (5/22) of
the patients with normal salivary ﬂow had PD. In
the negative group, loss of gingival attachment was
also more frequent among patients with hyposaliva-
tion (66.7% vs. 18.2%). Among HTLV-1 positive
patients, reduced salivary ﬂow was not associated
with periodontitis. Of those with normal and
TABLE III. Oral Health Proﬁle of Individuals From HTLV-1 Positive and Negative Groups
Variables
HTLV-1 infection
Positive (n ¼ 60) Negative (n ¼ 30)
P-valueN % N %
Dry mouth
Yes 28 46.7 6 20.0 0.020
No 32 53.3 24 80.0
Salivary flow
Normal 30 50.0 23 77.0 0.025
Reduced 30 50.0 7 23.0
Dental mobilitya
Yes 19 33.3 4 14.3 0.074
No 38 66.7 24 85.7
Periodontal diseasea
No disease 0 0.0 1 3.6 0.008
Gingivitis 21 36.8 18 64.3
Periodontitis 36 63.2 9 32.1
Gingival attachment lossa
0–3 mm 25 43.9 20 71.4 0.021
>4 mm 32 56.1 8 28.6
DMTF (mean  SD) 21  5.4 16.4  7.6 0.006
DMFT index, decayed, missing, and ﬁlled teeth.
aThe ‘‘n’’ for analysis of these variables were respectively 57 and 28, whereas excluded patients were edentulous.
Fig. 1. Correlation of proviral load in PBMC and saliva in HTLV-
1 positive individuals.
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decreased salivary ﬂow, 65.5% and 60.7% had peri-
odontitis, respectively.
It was only possible to perform PCR and molecular
cloning successfully using the DNA from saliva cells
in four (S2132, S3518, S3728, and S4192) of the eight
samples. These PCR products, and the corresponding
PCR products in the PBMC were cloned and a total
of 79 PBMC colonies and 74 saliva colonies were
obtained for plasmid DNA extraction. It was possible
to detect 27 PBMC clones and 28 mouthwash clones
in the analyzed colonies. The tax-LTR3’ fragment
obtained from these samples were submitted to
‘‘LASP HTLV-1 Automated Subtyping Tool’’ (http://
lasp.cpqgm.ﬁocruz.br) and all isolates were grouped
into the Transcontinental subgroup of Cosmopolitan
subtype.
When the PBMC and mouthwash virus isolates
from each individual were analyzed, it was observed
that there is no proﬁle among the LTR sequences
obtained from the mouthwash cells and PBMC from
all the individuals by the ML and NJ analyses.
The presence of post-translational modiﬁcation sites
in the sequenced tax region was equivalent among
the analyzed clones. The mean diversity within the
PBMC and mouthwash clones from each individual
was 0.005, 0.003, 0.008, and 0.007 for 2,132, 3,518,
3,728, and 4,192 patients, respectively. The panmixia
probability, demonstrated by p(Ks) and p(Ks),
showed no statistic signiﬁcance when comparing the
PBMC and mouthwash clones from individuals: 2,132,
p(Ks) ¼ 1 and p(Ks) ¼ 0.9257; 3,518, p(Ks) ¼ 1 and
p(Ks) ¼ 1; 3,728, p(Ks) ¼ 0.0078 and p(Ks) ¼
0.0078; and 4,192, p(Ks) ¼ 0.4790 and p(Ks) ¼
0.5355 (Table V).
DISCUSSION
HTLV-1 positive individuals had a higher frequency
of oral manifestations such as dry mouth (46.7% of
positive individuals and 20% of negative ones),
decreased salivary ﬂow (50% and 23%, respectively),
attachment loss up to 4 mm (56.1% and 28.6%), tooth
TABLE IV. Oral and Salivary Changes in HTLV-1-Infected Individuals According to HAM/TSP
Variables
HTLV-1-infected patients
No HAM/TSP HAM/TSP
P-valuen ¼ 35 % n ¼ 25 %
Salivary flow
Normal 18 51.4 12 48.0 1.000
Reduced 17 48.6 13 52.0
Dental mobilitya
Yes 10 29.4 9 39.1 0.569
No 24 70.6 14 60.9
Periodontal disease (PD)a
No disease 0 0.0 0 0.0 0.576
Gingivitis 14 41.2 7 30.4
Periodontitis 20 58.8 16 69.6
Gingival attachment lossa
0–3 mm 18 52.9 7 30.4 0.110
>4 mm 16 47.1 16 69.6
Oral manifestations
Healthy oral mucosa 20 57.1 17 68.0 0.291
Abscess/fistula 2 5.7 2 8.0
Stomatitis 13 37.2 6 24.0
DMTF (mean  SD) 20.64  5.6 21.1  5.3 0.286
DMFT index, decayed, missing, and ﬁlled teeth.
aThe ‘‘n’’ for analysis of these variables were respectively 57 and 28, whereas excluded patients were edentulous.
TABLE V. Molecular Analysis From Four Patients With HTLV-1 Proviral Load Detectable in Mouthwash Cells
Sample ID
HTLV-1 proviral load
Number of
analyzed clones Mean genetic diversity Panmixia probably
PBMC
(106 cells)
Mouthwash cells
(106 cells) PBMC
Mouthwash
cells PBMC
Mouthwash
cells
Mouthwash
cells  PBMC pKs pKs
2132 96196 210 03 05 0.003 0.007 0.005 1 0.9257
3518 583765 1300 03 03 0.003 0.003 0.003 1 1
3728 92772 600 17 02 0.007 0.002 0.012 0.0078 0.0078
4192 197217 794 04 18 0.007 0.007 0.007 0.4790 0.5355
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mobility (33.3% and 14.3%), and periodontitis (63.2%
and 32.1%). Seropositive individuals also presented
a higher oral lesion prevalence than seronegative
patients (38.3% and 13.3%, respectively) and DMFT
index (21  5.4 and 16.4  7.6, respectively). These
results are in accordance with the literature [Giozza,
2006] that reports poorer oral health status in HTLV-
1 individuals, compared to a control group.
Individuals with HAM/TSP had a higher proviral
load in the blood, as well as the number of copies of
HTLV-1 DNA in saliva than the asymptomatic ones.
In order to understand the possible correlation be-
tween HAM/TSP and proviral load in saliva, another
study with a larger sample would be required. With
regard to oral manifestation in individuals with HAM/
TSP, the data did not show signiﬁcant differences
when compared to asymptomatic carriers, although
the group of individuals with HAM/TSP presented a
higher percentage of decreased salivary ﬂow, peri-
odontal disease, and loss of gingival attachment when
compared with asymptomatic ones. Considering sali-
vary ﬂow, the present study is in agreement with a
previous report [Giozza, 2006] that described more
pronounced hyposalivation in HAM/TSP in relation to
asymptomatic carriers.
It is important to note that, comparing the relation-
ship between reduced salivary ﬂow and periodontal
disease in HTLV-1 infected and non-infected individu-
als, it was observed that in the control group there
was a positive association between periodontitis and
loss of gingival attachment with a reduction in sali-
vary ﬂow. However, in the group of HTLV positive
individuals, this association was not conﬁrmed.
Individuals with reduced ﬂow and normal ﬂow had
periodontal disease in a similar proportion. The role
of HTLV infection in the severity of periodontal
disease needs to be clariﬁed.
When performing the evaluation of the oral cavity
of HTLV-1 positive and negative subjects, regardless
of the proviral load in their saliva, an increased sever-
ity of periodontal disease in the group with HTLV-1
was clearly observed, where the majority (63%) had
periodontitis. A previous report suggested that the
HTLV-1 infection may be implicated in periodontal
disease due to the altered levels of cytokines [Garlet
et al., 2010], which promotes an exacerbated inﬂam-
matory immune response, possibly associated with an
impaired Treg activity, in response to a usual pattern
of periodontal infection.
It is important to note that complaints of xerostomy
may not be directly related to reduced salivary ﬂow.
A study using questionnaires and sialometry was car-
ried out [Korn et al., 2002] and demonstrated that
46.7% of seropositive individuals reported dry mouth,
while a reduction in salivary ﬂow was found in 50%.
Literature reports a correlation between HTLV-1
infection and sicca syndrome (keratoconjunctivitis
sicca and hyposalivation), regardless of the presence
of Sjo¨gren’s syndrome [Giozza, 2006; Ferraz-Chaoui
et al., 2010].
Many diseases that are associated with HTLV-1
may compromise the patients’ quality of life in various
ways. For this reason several indicators have been
recorded in this study, including dysphagia (due to
decreased salivary ﬂow), the complaint of dry mouth,
dry eyes, and depression. However, it is important to
highlight the fact that oral diseases, particularly car-
ies and periodontitis, have multifactorial causes and
various aspects should be examined. When studying
these pathologies, it is also important to include
environmental factors, diet, habits, and the presence
of systemic involvement that may contribute to
the development of oral disease [Peres et al., 2003;
Ragghianti et al., 2004; Gushi et al., 2005].
In the present research, the prevalence of HTLV-1
was higher in people with low levels of education and
low income, corroborating previous reports [Dourado
et al., 2003; Mota et al., 2006]. In addition, literature
has shown that income and educational level are
other aspects that must be considered when evaluat-
ing caries and periodontal disease [Jovino-Silveira
et al., 2005]. As with HTLV-1, the prevalence of oral
diseases is inversely proportional in individuals with
lower educational levels and lower income. Thus, oral
manifestations in patients with HTLV-1 should be an-
alyzed with caution, taking into account the variables
involved in order to establish any causal relationship.
The presence of provirus in saliva seems to be relat-
ed to a high level of proviral load in peripheral blood.
This ﬁnding may mean that a high proviral load may
potentially induce systemic inﬂammatory manifesta-
tions as occurs in HAM/TSP. On the other hand, only
one individual who had a proviral load detected in
mouthwash cells presented lower levels of PBMC pro-
viral load. Because of the fact that studies evaluating
the antibody response in saliva suggest a weak im-
mune response to HTLV-1 in saliva, which could be
an important factor in the increase in the proviral
load [Belec et al., 1996], it is possible to infer that the
proviral load detected in the saliva could be the result
of an immune system balance in this corporeal ﬂuid.
This possibility highlights the risk of the presence of a
few infected cells in the saliva, an important via of
transmission, without any sign of detection through
proviral load, when the immune response is able to
control the virus spread.
As regards intra-host variations, the analysis
included clones from three levels of proviral load, and
no difference was identiﬁed. This result conﬁrms the
need to perform a similar study with a longer virus
genomic fragment in order to obtain more informa-
tion, and this will probably detect some variation
when comparing individuals. The low genetic diversi-
ty suggests, unlike HIV, that the HTLV-1 is a long
latency virus, spreading slowly in infected patients
due to the slow replication cycle.
The panmixia probability showed that the PBMC
and mouthwash clones from individuals were from a
common ancestor, suggesting that there is no muta-
tional proﬁle determining the HTLV-1-infected cells
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in mouthwash. HTLV-1 in saliva is probably a result
of the inﬁltration of lymphocytes by oral mucosa
lesions, and high levels of proviral load in peripheral
blood.
HTLV-1 transmission occurs mainly by cell-to-cell
contact or cell-to-cell fusion (also named syncytium
formation). The gp46 protein codiﬁed by the envelop
gene is responsible for the main antibody response
against HTLV-1. Antibody IgG anti-gp46 peptides are
capable of neutralizing the syncytium formation
therefore HTLV-1 transmission from person to person
by kissing or sharing tableware, if it occurs, seems
rare.
In conclusion, this study found that HTLV-1
patients have poorer oral health status, characterized
by decreased salivary ﬂow, advanced periodontitis,
and loss of gingival attachment when compared to
seronegative individuals. A weak positive correlation
between blood and saliva proviral loads was observed
and the amount of virus detected in the saliva was
lower than that detected in the blood. The mean val-
ues of proviral load in blood and saliva in patients
with HAM/TSP was greater than those in HTLV-1
carriers. The HTLV-1 molecular analysis from PBMC
and saliva specimens suggests that the HTLV-1 in
saliva is due to lymphocyte inﬁltration from peripher-
al blood.
HAM/TSP patients had a higher frequency of oral
disease in relation to asymptomatic individuals. A
direct relationship between proviral load in saliva and
oral manifestations was also observed. Another study
with a large sample, including a salivary gland biop-
sy, would be necessary not only to obtain the diagno-
sis of Sjo¨gren’s syndrome, but also to investigate the
possible relationship between glandular lymphocytic
inﬁltratation and hyposalivation. Histopathological
examination, with supplementary immunohistochem-
istry, would be helpful in order to understand the role
of the HTLV in the pathogenesis of sialadenitis and
periodontal disease better. The fact that lymphocytes
are scarce in the saliva, but are present in glandular
inﬂammation should also be investigated. The provi-
ral load in the salivary gland may be higher than in
saliva.
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